REFERENCES
- Zheng Z J, Croft J B, Giles W H, Mensah G A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158–63, [INFOTRIEVE], [CSA]
- American Heart Association. Pharmacology II: agents to optimize cardiac output andblood pressure. Circulation 2000; 102(Suppl)I-129–135, [CSA]
- Standards for cardiopulmonary resuscitation (CPR) andemergency cardiac care (ECC). V. Medicolegal considerations andrecommendations. JAMA 1974; 227(Suppl)864–8, [CROSSREF], [CSA]
- Mayr V D, Wenzel V, Wodckel W G, et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001; 104: 1651–6, [INFOTRIEVE], [CSA]
- Zhong J -Q., Dorian P. Epinephrine andvasopressin during cardiopulmonary resuscitation. Resuscitation 2005; 66: 263–299, [INFOTRIEVE], [CROSSREF], [CSA]
- Morley P. Vasopressin or epinephrine: which initial vasopressor for cardiac arrests?. Lancet 2001; 358: 85–96, [INFOTRIEVE], [CROSSREF], [CSA]
- Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest. JAMA 2005; 293: 299–304, [INFOTRIEVE], [CROSSREF], [CSA]
- Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review andmeta-analysis. Arch Intern Med 2005; 165: 17–24, [INFOTRIEVE], [CROSSREF], [CSA]
- Vandycke C, Martens P. High dose versus standard dose epinephrine in cardiac arrest—a meta analysis. Resuscitation 2000; 45: 161–6, [INFOTRIEVE], [CROSSREF], [CSA]